Abstract:
Compositions and Methods for Stabilizing Circulating Tumor Cells Methods and compositions for stabilizing a biological sample for analysis, comprising the steps of obtaining in a sample collection device a biological sample from a subject, especially blood, the biological sample including at least one circulating tumor cell from the subject. The methods may include a step of contacting the biological sample with a protective agent composition that includes a preservative agent, an optional anticoagulant, and a quenching agent to form a mixture that includes the protective agent composition and the sample.
Abstract:
Un procedimiento de estabilización de ARN fuera de las células dentro de una muestra de sangre extraída para el análisis que comprende extraer la muestra de sangre en un tubo de recogida de sangre que comprende: a. de 0,5 % a 20 % en peso de un inhibidor de nucleasa seleccionado de uno o más de pirocarbonato de dietilo, etanol, ácido aurintricarboxílico (ATA), formamida, complejos de vanadil-ribonucleósidos, macaloides, ácido etilendiaminotetraacético (EDTA), proteinasa K, heparina, hidroxilamina-oxígeno-ion cúprico, bentonita, sulfato de amonio, ditiotreitol (DTT), beta-mercaptoetanol, cisteína, ditioeritritol, y clorhidrato de tris(2-carboxietil)fosfina; b. de 20 % a 30 % en peso de un agente conservante, en el que el agente conservante se selecciona de diazolidinil urea y/o imidazolidinil urea.
Abstract:
Compositions for preserving and processing fetal nucleic acids located within maternal blood samples are disclosed, wherein a sample of maternal blood containing fetal nucleic acids is treated with a composition to reduce both cell lysis of the maternal blood cells and deoxyribonuclease (DNase) and ribonuclease (RNase) activity within the fetal nucleic acids. Treatment of the sample with a composition as disclosed herein aids in increasing the arnount of fetal nucleic acids that can be identified and tested while maintaining the structure and integrity of the fetal nucleic acids.
Abstract:
A method for preserving and processing nucleic acids located within a blood sample is disclosed, wherein a blood sample containing nucleic acids is treated to reduce both blood cell lysis and nuclease activity within the blood sample. The treatment of the sample aids in increasing the integrity and amount of cellular nucleic acids that can be identified and tested while avoiding contamination of the isolated nucleic acids with cell -free nucleic acids. The preferred compositions for preserving and processing contain diazolidinyl urea (DU), EDTA, aurintricarboxylic acid (ATA), glyceraldehyde and sodium floride.
Abstract:
Methods and devices for stabilizing and preserving circulating cell- free plasma DNA for analysis are disclosed. The methods and devices use diazolidinyl urea or imidazolidinyl urea as a preservative, EDTA as an anticoagulant and glycine as a quenching agent to quench any free formaldehyde from the protective composition.
Abstract:
Un procedimiento exploratorio no invasivo prenatal para la identificación de características fetales, que comprende las etapas de: poner en contacto una muestra de sangre materna extraída, que incluye una pluralidad de células sanguíneas, con un agente protector de ácido nucleico, para evitar que las células sanguíneas (i) liberen ácidos nucleicos genómicos a la muestra de sangre y (ii) experimenten una actividad nucleasa que degrade los ácidos nucleicos fetales; aislar los ácidos nucleicos fetales de la muestra de sangre materna; y analizar los ácidos nucleicos fetales aislados para identificar una característica fetal en el que el agente protector incluye glicina e imidazolidinil urea, y ácido etilendiaminotetraacético en el que el agente protector contiene menos del 1 % en peso de formaldehído.
Abstract:
Compositions and Methods for Stabilizing Circulating Tumor Cells Methods and compositions for stabilizing a biological sample for analysis, comprising the steps of obtaining in a sample collection device a biological sample from a subject, especially blood, the biological sample including at least one circulating tumor cell from the subject. The methods may include a step of contacting the biological sample with a protective agent composition that includes a preservative agent, an optional anticoagulant, and a quenching agent to form a mixture that includes the protective agent composition and the sample.
Abstract:
A method for preserving and processing fetal nucleic acids located within maternal plasma is disclosed, wherein a sample of maternal blood containing fetal nucleic acids is treated to reduce both cell lysis of the maternal blood cells and deoxyribonuclease (DNase) and ribonuclease (RNase) activity within the fetal nucleic acids. The treatment of the sample aids in increasing the amount of fetal nucleic acids that can be identified and tested while maintaining the structure and integrity of the fetal nucleic acids.